NRX Pharmaceuticals, Inc. (NRXP)
2.68
+0.09
(+3.47%)
USD |
NASDAQ |
Oct 15, 14:43
NRX Pharmaceuticals Market Cap : 115.66M for Oct. 15, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 14, 2026 | 111.78M |
| October 13, 2026 | 116.53M |
| October 12, 2026 | 123.00M |
| October 09, 2026 | 123.00M |
| October 08, 2026 | 124.73M |
| October 07, 2026 | 125.16M |
| October 06, 2026 | 126.88M |
| October 05, 2026 | 123.86M |
| October 02, 2026 | 125.37M |
| October 01, 2026 | 123.00M |
| September 30, 2026 | 126.02M |
| September 29, 2026 | 126.02M |
| September 28, 2026 | 123.86M |
| September 25, 2026 | 129.26M |
| September 24, 2026 | 130.77M |
| September 23, 2026 | 136.38M |
| September 22, 2026 | 143.28M |
| September 21, 2026 | 141.99M |
| September 18, 2026 | 143.28M |
| September 17, 2026 | 146.30M |
| September 16, 2026 | 144.58M |
| September 15, 2026 | 146.74M |
| September 14, 2026 | 150.62M |
| September 11, 2026 | 146.74M |
| September 10, 2026 | 146.74M |
| Date | Value |
|---|---|
| September 09, 2026 | 145.44M |
| September 08, 2026 | 149.76M |
| September 04, 2026 | 150.62M |
| September 03, 2026 | 148.03M |
| September 02, 2026 | 149.33M |
| September 01, 2026 | 148.46M |
| August 31, 2026 | 150.19M |
| August 28, 2026 | 153.21M |
| August 27, 2026 | 156.23M |
| August 26, 2026 | 149.33M |
| August 25, 2026 | 158.39M |
| August 24, 2026 | 148.89M |
| August 21, 2026 | 153.64M |
| August 20, 2026 | 151.48M |
| August 19, 2026 | 143.72M |
| August 18, 2026 | 148.46M |
| August 17, 2026 | 148.03M |
| August 14, 2026 | 141.13M |
| August 13, 2026 | 144.15M |
| August 12, 2026 | 145.01M |
| August 11, 2026 | 146.74M |
| August 10, 2026 | 112.13M |
| August 07, 2026 | 119.83M |
| August 06, 2026 | 103.43M |
| August 05, 2026 | 102.25M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.658B |
| Corcept Therapeutics, Inc. | 12.22B |
| Veru, Inc. | 40.92M |
| Johnson & Johnson | 610.65B |
| Eli Lilly & Co. | 1.193T |
Market Cap Related Metrics
| PS Ratio | 24.47 |
| Price | 2.68 |
| Earnings Yield | -27.49% |